Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

[1]  C. Schoenborn,et al.  Health promotion and disease prevention: United States, 1990. , 1993, Vital and health statistics. Series 10, Data from the National Health Survey.

[2]  P. Whelton,et al.  Vascular reactivity in young adults and cardiovascular disease. A prospective study. , 1992, Hypertension.

[3]  N. Bellamy.  Prognosis in the Rheumatic Diseases , 2012, Springer Netherlands.

[4]  D. Wallace,et al.  Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. , 1990, The American journal of medicine.

[5]  M. Hochberg,et al.  Systemic lupus erythematosus. , 1990, Rheumatic diseases clinics of North America.

[6]  S. Shapiro,et al.  Decline in the risk of myocardial infarction among women who stop smoking. , 1990, The New England journal of medicine.

[7]  J. Reveille,et al.  Prognosis in systemic lupus erythematosus , 1990 .

[8]  G. Hughes,et al.  The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.

[9]  E. Raz,et al.  Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.

[10]  M. Sakauchi,et al.  Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisolone. , 1989, Japanese journal of medicine.

[11]  O. Nived,et al.  Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population , 1989, Medicine.

[12]  D. Renlund,et al.  Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. , 1988, The American journal of medicine.

[13]  E. Ginzler,et al.  Outcome and prognosis in systemic lupus erythematosus. , 1988, Rheumatic diseases clinics of North America.

[14]  S. Ikehara,et al.  Quantitative analysis of myocardial infarction in (NZW x BXSB)F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. , 1987, The American journal of pathology.

[15]  W. Willett,et al.  Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. , 1987, The New England journal of medicine.

[16]  A. Goldberg,et al.  Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. , 1987, The American journal of medicine.

[17]  W. Baumgartner,et al.  Prevalence of hyperlipidemia in heart transplant recipients. , 1987 .

[18]  D. Gladman,et al.  Morbidity in systemic lupus erythematosus. , 1987, The Journal of rheumatology. Supplement.

[19]  M. Petri,et al.  The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. , 1987, Annals of internal medicine.

[20]  M. Kinjo,et al.  CORONARY ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AT AUTOPSY , 1987, Acta pathologica japonica.

[21]  I. Mackay,et al.  Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid. , 1986, British heart journal.

[22]  E F Heineman,et al.  Cardiovascular disease risk factors and mortality among black women and white women aged 40-64 years in Evans County, Georgia. , 1986, American journal of epidemiology.

[23]  M. Delezé,et al.  Cardiovascular Manifestations in Systemic Lupus Erythematosus. Prospective Study of 100 Patients , 1985, Angiology.

[24]  D. Gladman,et al.  Mortality in systemic lupus erythematosus: the bimodal pattern revisited. , 1985, The Quarterly journal of medicine.

[25]  R. Bennett,et al.  Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. , 1984, The American journal of medicine.

[26]  S. Eisenberg,et al.  The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. , 1984, Metabolism: clinical and experimental.

[27]  B. Ansell,et al.  The Heart and rheumatic disease , 1984 .

[28]  S. Johansson,et al.  Myocardial infarction in women. , 1986, Epidemiologic reviews.

[29]  H. Spiera,et al.  Myocardial infarction in four young patients with SLE. , 1983, The Journal of rheumatology.

[30]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[31]  J. Fries,et al.  A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. , 1982, Arthritis and rheumatism.

[32]  J. Fries,et al.  A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. , 1982, Arthritis and rheumatism.

[33]  J. Fallon,et al.  Ischemie heart disease in systemic lupus erythematosus in the young patient: Report of six cases , 1982 .

[34]  W. Roberts,et al.  Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. , 1981, The American journal of medicine.

[35]  D. Wallace,et al.  Systemic lupus erythematosus--survival patterns. Experience with 609 patients. , 1981, JAMA.

[36]  E. Lewis,et al.  Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. , 1980, The American journal of medicine.

[37]  Urowitz Mb,et al.  Late mortality in SLE--"the price we pay for control". , 1980 .

[38]  Y. Hiramatsu,et al.  Cardiovascular Manifestations in Systemic Lupus Erythematosus : SYMPOSIUM ON SECONDARY MYOCARDIAL DISEASE : 44th Scientific Session of the Japanise Circulation Society , 1979 .

[39]  D. Cattran,et al.  Hyperlipidemia after renal transplantation: natural history and pathophysiology. , 1979, Annals of internal medicine.

[40]  L. Accinni,et al.  Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome. , 1979, The American journal of pathology.

[41]  W. Kannel,et al.  A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.

[42]  J. Shaver,et al.  Coronary arteritis in systemic lupus erythematosus. , 1976, Chest.

[43]  M. Urowitz,et al.  The bimodal mortality pattern of systemic lupus erythematosus. , 1976, The American journal of medicine.

[44]  W. Roberts,et al.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: A study of 36 necropsy patients , 1975 .

[45]  E. Donoso,et al.  Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus. , 1975, The American journal of cardiology.

[46]  L. Blieden,et al.  Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus. , 1974, American heart journal.

[47]  T. Bonfiglio,et al.  Coronary arteritis, occlusion, and myocardial infarction due to lupus erythematosus. , 1972, American heart journal.

[48]  N. Rothfield,et al.  RENAL DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS. , 1963, The New England journal of medicine.